Published in Health Business Week, June 30th, 2006
The company also entered into a development and supply agreement with Merial, Ltd., for the Vitajet 3 needle-free device.
At the annual shareholder meeting, held May 24, 2006, the shareholders approved the issuance of approximately $4.5 million of Series E Preferred Stock to affiliates of SMH. Under the terms of the agreement with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.